GSK Arm Wins Appeal In Cancer Drug Royalties Dispute
聽A GlaxoSmithKline unit won its appeal Friday to avoid having to pay royalties to AstraZeneca on all sales of its ovarian cancer drug under a licensing agreement....To view the full article, register now.
Already a subscriber? Click here to view full article